BlackRock’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Sell |
370,076
-830,485
| -69% | -$1.04M | ﹤0.01% | 4392 |
|
|
2025
Q1 | $3.88M | Buy |
1,200,561
+143,586
| +14% | +$464K | ﹤0.01% | 3699 |
|
|
2024
Q4 | $4.35M | Buy |
1,056,975
+690,097
| +188% | +$2.84M | ﹤0.01% | 3731 |
|
|
2024
Q3 | $2.36M | Buy |
366,878
+278,979
| +317% | +$1.79M | ﹤0.01% | 3901 |
|
|
2024
Q2 | $423K | Buy |
+87,899
| New | +$423K | ﹤0.01% | 4335 |
|